The Ministry of Food and Drug Safety said Thursday it is launching a crackdown on illegal online sales, brokering and advertising of GLP-1 obesity drugs amid increasing demand. The crackdown covers sales through direct purchases from overseas sellers and secondhand trading. The ministry warned that individuals who bring in such drugs from abroad for personal treatment violate the Pharmaceutical Affairs Act if they resell them or give them to others. It plans to take stern action against violators, including requesting investigations and filing criminal complaints. Since Nov. 12, the government has allowed up to a three-month supply of obesity drugs prescribed overseas to be carried into the country. The change has raised concerns that more buyers would purchase cheaper drugs such as Mounjaro and Wegovy there to resell at home. Exact prices may vary, but a four-week supply of Mounjaro at its lowest dose costs about 300,000 won ($224) in Korea, roughly three times what some medical institutions in Japan charge. The ministry has set up a reporting center and a task force to monitor and inv
Read full article